• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧细胞毒素1,2 - 二氢 - 8 -(4 - 甲基哌嗪基)- 4 - 苯基咪唑并[1,2 - a]吡啶并[3,2 - e]吡嗪5 - 氧化物(RB90740)的辐射分解和光化学还原以及缺氧选择性毒性的潜在机制

Radiolytic and photochemical reduction of the hypoxic cytotoxin 1,2-dihydro-8-(4-methylpiperazinyl)-4-phenylimidazo [1,2-a] pyrido [3,2-e] pyrazine 5-oxide (RB90740) and a potential mechanism for hypoxia-selective toxicity.

作者信息

Naylor M A, Sutton B M, Nolan J, O'Neill P, Fielden E M, Adams G E, Stratford I J

机构信息

MRC Radiobiology Unit, Chilton, Didcot, Oxon, UK.

出版信息

Int J Radiat Oncol Biol Phys. 1994 May 15;29(2):333-7. doi: 10.1016/0360-3016(94)90285-2.

DOI:10.1016/0360-3016(94)90285-2
PMID:8195029
Abstract

PURPOSE

To study the reduction of RB90740 (1), a fused pyrazine mono-N-oxide that has an oxic:hypoxic cytotoxicity ratio of > 10 in a range of murine and human tumor cells in vitro.

METHODS AND MATERIALS

Reduction of 1 has been initiated radiolytically and photochemically in aqueous solution and the products isolated and characterized by high performance liquid chromatography (HPLC).

RESULTS

Radiolytic reduction of 1 leads to the formation of the 2-electron reduced product, 2. The stoichiometry of the reduction is pH dependent, increasing from 1 to 2 with increasing pH, but independent of the presence of formate or 2-methyl 2-propanol in the reduction mixture. A dimerization product, 3, is also found, which is produced in greater yields at lower pH (< 6). Photochemical reduction of 1 to 2 was also found to be facile. Photolysis of 1 also leads to a deoxyribonucleic acid cleavage reaction.

CONCLUSION

Since 2 is not cytotoxic towards hypoxic cells at concentrations at which 1 is toxic, a probable candidate as the cytotoxic species under hypoxic conditions is the 1-electron reduced intermediate species.

摘要

目的

研究RB90740(1)的还原情况,RB90740是一种稠合吡嗪单N -氧化物,在一系列小鼠和人类肿瘤细胞体外实验中,其有氧:无氧细胞毒性比>10。

方法与材料

在水溶液中通过辐射分解和光化学方法引发1的还原反应,产物通过高效液相色谱(HPLC)进行分离和表征。

结果

1的辐射还原反应生成了双电子还原产物2。还原反应的化学计量比取决于pH值,随着pH值升高从1增加到2,但与还原混合物中是否存在甲酸盐或2 -甲基- 2 -丙醇无关。还发现了一种二聚产物3,在较低pH值(<6)下产量更高。还发现1光化学还原为2很容易。1的光解反应还会导致脱氧核糖核酸裂解反应。

结论

由于2在1有毒的浓度下对缺氧细胞没有细胞毒性,因此在缺氧条件下作为细胞毒性物质的可能候选物是单电子还原中间体。

相似文献

1
Radiolytic and photochemical reduction of the hypoxic cytotoxin 1,2-dihydro-8-(4-methylpiperazinyl)-4-phenylimidazo [1,2-a] pyrido [3,2-e] pyrazine 5-oxide (RB90740) and a potential mechanism for hypoxia-selective toxicity.缺氧细胞毒素1,2 - 二氢 - 8 -(4 - 甲基哌嗪基)- 4 - 苯基咪唑并[1,2 - a]吡啶并[3,2 - e]吡嗪5 - 氧化物(RB90740)的辐射分解和光化学还原以及缺氧选择性毒性的潜在机制
Int J Radiat Oncol Biol Phys. 1994 May 15;29(2):333-7. doi: 10.1016/0360-3016(94)90285-2.
2
Pharmacokinetics, metabolism and distribution of 1,2-dihydro-8-(4-methylpiperazinyl)-4-phenylimidazo [1,2-A] pyrido [3,2-E] pyrazine-5-oxide in C3H mice.
Int J Radiat Oncol Biol Phys. 1994 May 15;29(2):339-44. doi: 10.1016/0360-3016(94)90286-0.
3
Enzymology of the reduction of the novel fused pyrazine mono-n-oxide bioreductive drug, RB90740 roles for P450 reductase and cytochrome b5 reductase.
Biochem Pharmacol. 1996 Mar 22;51(6):829-37. doi: 10.1016/0006-2952(95)02257-0.
4
Heterocyclic mono-N-oxides with potential applications as bioreductive anti-tumour drugs: Part 1. 8-Alkylamino-substituted phenylimidazo [1,2-a] quinoxalines.具有作为生物还原抗肿瘤药物潜在应用的杂环单 N-氧化物:第 1 部分。8-烷基氨基取代的苯基咪唑并[1,2-a]喹喔啉
Anticancer Drug Des. 1993 Dec;8(6):439-61.
5
Chemical properties which control selectivity and efficacy of aromatic N-oxide bioreductive drugs.控制芳香族N-氧化物生物还原药物选择性和疗效的化学性质。
Br J Cancer Suppl. 1996 Jul;27:S70-4.
6
In vitro cytotoxicity of pyrazine-2-diazohydroxide: specificity for hypoxic cells and effects of microsomal coincubation.
Invest New Drugs. 1988 Apr;6(1):3-9. doi: 10.1007/BF00170773.
7
Fused pyrazine mono-n-oxides as bioreductive drugs. II Cytotoxicity in human cells and oncogenicity in a rodent transformation assay.稠合吡嗪单 N -氧化物作为生物还原药物。II. 对人细胞的细胞毒性及在啮齿动物转化试验中的致癌性
Int J Radiat Oncol Biol Phys. 1996 Jan 1;34(1):79-84. doi: 10.1016/0360-3016(95)02077-2.
8
Indolequinone antitumor agents: reductive activation and elimination from (5-methoxy-1-methyl-4,7-dioxoindol-3-yl)methyl derivatives and hypoxia-selective cytotoxicity in vitro.吲哚醌类抗肿瘤药物:(5-甲氧基-1-甲基-4,7-二氧代吲哚-3-基)甲基衍生物的还原激活与消除及体外缺氧选择性细胞毒性
J Med Chem. 1998 Jul 16;41(15):2720-31. doi: 10.1021/jm970744w.
9
Reductive chemistry of the novel hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.新型低氧选择性细胞毒素5-[N,N-双(2-氯乙基)氨基]-2,4-二硝基苯甲酰胺的还原化学
J Med Chem. 1995 Mar 31;38(7):1229-41. doi: 10.1021/jm00007a019.
10
Fused pyrazine mono-N-oxides as bioreductive drugs. III. Characterization of RB 90740 in vitro and in vivo.稠合吡嗪单-N-氧化物作为生物还原药物。III. RB 90740的体外和体内特性研究
Anticancer Drugs. 1995 Apr;6(2):259-69. doi: 10.1097/00001813-199504000-00010.

引用本文的文献

1
Hypoxia-targeted drug delivery.缺氧靶向药物递送。
Chem Soc Rev. 2019 Feb 4;48(3):771-813. doi: 10.1039/c8cs00304a.
2
Chemical properties which control selectivity and efficacy of aromatic N-oxide bioreductive drugs.控制芳香族N-氧化物生物还原药物选择性和疗效的化学性质。
Br J Cancer Suppl. 1996 Jul;27:S70-4.
3
Oncogenic potential of bifunctional bioreductive drugs.双功能生物还原药物的致癌潜力。
Br J Cancer Suppl. 1996 Jul;27:S57-60.